Skip to main content
. 2020 Dec 29;11:612632. doi: 10.3389/fneur.2020.612632

Table 1.

Baseline characteristics of 108 patients of anti-NMDARE enrolled in the study.

Factor mRS ≤ 2 mRS > 2 P-value
Number of cases 74 34
Gender 0.679
1 38 (51%) 16 (47%)
2 36 (49%) 18 (53%)
Age 0.127
<15 17 (23%) 3 (9%)
15–24 28 (38%) 10 (29%)
25–34 22 (30%) 15 (44%)
35–45 7 (9%) 6 (18%)
Memory dysfunction 0.241
0 52 (70%) 20 (59%)
1 22 (30%) 14 (41%)
Speech disorders 0.24
0 54 (73%) 21 (62%)
1 20 (27%) 13 (38%)
Behavioral changes 0.123
0 31 (42%) 9 (26%)
1 43 (58%) 25 (74%)
Seizures 0.458
0 25 (34%) 14 (41%)
1 49 (66%) 20 (59%)
Consciousness disorder 0.003
0 63 (85%) 20 (59%)
1 11 (15%) 14 (41%)
Sleep dysfunction 0.579
0 62 (84%) 27 (79%)
1 12 (16%) 7 (21%)
Movement disorder 0.016
0 58 (78%) 19 (56%)
1 16 (22%) 15 (44%)
Autonomic dysfunction 0.131
0 71 (96%) 30 (88%)
1 3 (4%) 4 (12%)
Viral prodrome 0.145
0 35 (47%) 11 (32%)
1 39 (53%) 23 (68%)
CSF WBC count (>20 cell/μL) 0.105
0 45 (61%) 15 (44%)
1 29 (39%) 19 (56%)
CSF protein (>30 mg/dL) 0.914
0 34 (46%) 16 (47%)
1 40 (54%) 18 (53%)
Abnormal MRI 0.761
0 28 (38%) 12 (35%)
1 45 (62%) 22 (65%)
Tumor 0.571
0 70 (95%) 33 (97%)
1 4 (5%) 1 (3%)
Immunotherapy latency (>4 wk) 0.077
0 44 (59%) 14 (41%)
1 30 (41%) 20 (59%)

Data presented as n (%).

mRS, modified Rankin Scale; anti-NMDARE, anti-N-methyl-D-aspartate receptor encephalitis; CSF, cerebrospinal fluid; WBC, white blood cell; MRI, magnetic resonance imaging.

Univariate binary logistic regression analysis was conducted using the Fisher exact test; the P-value was derived from bivariate association analyses between each study variables and the mRS score.